Pilot study of reduced‐intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis
Open Access
- 21 February 2005
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 128 (5) , 690-697
- https://doi.org/10.1111/j.1365-2141.2005.05373.x
Abstract
A prospective pilot study was performed to evaluate the effect of reduced-intensity conditioning with busulphan (10 mg/kg), fludarabine (180 mg/qm) and anti-thymocyte globulin followed by allogeneic stem cell transplantation from related (n = 8) and unrelated donors (n = 13) in 21 patients with myelofibrosis. The median age of the patients was 53 years (range, 32–63). No primary graft failure occurred. The median time until leucocyte (>1·0 × 109/l) and platelet (>20 × 109/l) engraftment was 16 (range, 11–26) and 23 d (range, 9–139) respectively. Complete donor chimaerism on day 100 was seen in 20 patients (95%). Acute graft-versus-host disease (GvHD) grades II–IV and III/IV occurred in 48% and 19% of cases and 55% of the patients had chronic GvHD. Treatment-related mortality was 0% at day 100 and 16% [95% confidence interval (CI): 0–32%] at 1 year. Haematological response was seen in 100% and complete histopathological remission was observed in 75% of the patients and 25% of the patients showed partial histopathological remission with a continuing decline in the grade of fibrosis. After a median follow-up of 22 months (range, 4–59), the 3-year estimated overall and disease-free survival was 84% (95% CI: 67–100%).Keywords
This publication has 31 references indexed in Scilit:
- Allogeneic hematopoietic stem cell transplantation for myelofibrosisBlood, 2003
- Stem cell transplantation for myelofibrosis: a report from two Canadian centersBone Marrow Transplantation, 2003
- Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasiaBlood, 2002
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation: demonstration of a graft-versus-myelofibrosis effectBone Marrow Transplantation, 2000
- Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a ‘graft vs. myelofibrosis’ effectBritish Journal of Haematology, 2000
- Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groupsBritish Journal of Haematology, 1998
- The very‐long‐term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study GroupBritish Journal of Haematology, 1994
- Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patientsBritish Journal of Haematology, 1990
- Essential thrombocythemias. Clinical evolutionary and biological dataCancer, 1986